We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Voya Financial
VOYA
$8.9B
| $3.5M | 0.01% |
59,646
-41,225
| -41% | -$2.65M |
|
902
Emergent Biosolutions
EBS
$228M
| $3.48M | 0.01% |
114,639
+28,688
| +33% | +$979K |
|
903
Stewart Information Services
STC
$2B
| $3.46M | 0.01% |
69,630
+16,532
| +31% | +$887K |
|
904
Elastic
ESTC
$7.94B
| $3.46M | 0.01% |
51,150
-22,413
| -30% | -$1.63M |
|
|
DRE
905
DELISTED
Duke Realty Corp.
DRE
| $3.45M | 0.01% |
63,803
+17,774
| +39% | +$973K |
|
906
Chipotle Mexican Grill
CMG
$40.5B
| $3.44M | 0.01% |
133,900
-289,150
| -68% | -$8.06M |
|
|
CNR
907
Core Natural Resources Inc
CNR
$4.65B
| $3.43M | 0.01% |
69,470
+11,605
| +20% | +$565K |
|
908
Avient
AVNT
$4.17B
| $3.43M | 0.01% |
86,966
+38,949
| +81% | +$1.84M |
|
|
CPRX
909
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.42M | 0.01% |
487,541
+73,989
| +18% | +$543K |
|
910
Encore Capital Group
ECPG
$1.98B
| $3.42M | 0.01% |
59,131
+37,023
| +167% | +$2.19M |
|
911
Waterstone Financial
WSBF
$374M
| $3.41M | 0.01% |
199,849
+20,357
| +11% | +$350K |
|
912
Valmont Industries
VMI
$9.52B
| $3.4M | 0.01% |
15,476
-741
| -5% | -$181K |
|
913
STAG Industrial
STAG
$7.08B
| $3.39M | 0.01% |
109,766
-33,450
| -23% | -$1.19M |
|
914
Xylem
XYL
$28.8B
| $3.38M | 0.01% |
43,954
-3,135
| -7% | -$259K |
|
915
Argan
AGX
$8.11B
| $3.38M | 0.01% |
90,448
+22,837
| +34% | +$875K |
|
916
ProPetro Holding
PUMP
$1.43B
| $3.37M | 0.01% |
337,066
+94,018
| +39% | +$1.24M |
|
|
TTM
917
DELISTED
Tata Motors Limited
TTM
| $3.37M | 0.01% |
130,228
+18,187
| +16% | +$498K |
|
|
HSII
918
DELISTED
Heidrick & Struggles
HSII
| $3.36M | 0.01% |
103,924
+42,253
| +69% | +$1.45M |
|
919
RenaissanceRe
RNR
$13.2B
| $3.35M | 0.01% |
21,616
+7,659
| +55% | +$1.16M |
|
920
Portland General Electric
POR
$5.69B
| $3.33M | 0.01% |
69,001
-7,366
| -10% | -$367K |
|
921
Gaming and Leisure Properties
GLPI
$12.4B
| $3.33M | 0.01% |
73,021
-188,230
| -72% | -$8.6M |
|
922
Acco Brands
ACCO
$396M
| $3.33M | 0.01% |
509,929
+247,444
| +94% | +$1.8M |
|
|
WLL
923
DELISTED
Whiting Petroleum Corporation
WLL
| $3.33M | 0.01% |
48,927
+4,673
| +11% | +$377K |
|
924
Independent Bank Corp
IBCP
$844M
| $3.32M | 0.01% |
172,223
+47,936
| +39% | +$952K |
|
925
GrafTech
EAF
$206M
| $3.31M | 0.01% |
46,838
+13,884
| +42% | +$1.21M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.